Cardioxane

Cardioxane (Dexrazoxane) is an intravenous medication used to reduce heart damage from certain chemotherapy treatments. It is manufactured by Clinigen Healthcare B.V. and is available in the EU.

Cardioxane is primarily used to protect the heart from damage caused by specific chemotherapy drugs. It is often administered to patients undergoing treatments that may lead to cardiotoxicity. The medication helps to mitigate the risk of heart-related side effects, allowing patients to continue their cancer treatment with reduced cardiac risk.

Cardioxane works by interfering with the cellular mechanisms that can lead to heart damage. Common effects may include temporary changes in blood pressure or heart rate, as well as mild injection site reactions. These effects are generally monitored by healthcare professionals during administration.

Cardioxane should be administered under the supervision of a healthcare professional. Patients with pre-existing heart conditions should discuss their medical history with their doctor before starting treatment. It is important to follow all safety guidelines provided by the healthcare provider.

Cardioxane may interact with other medications, particularly those that affect the heart or blood pressure. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect how the body responds to Cardioxane.